FDA withdraws its proposal for asbestos testing of talc-containing cosmetics
FDA published this proposed rule in the Federal Register. The original notice is document 2025-21407.
Verified updates archive
Browse U.S. mass tort news by month. Each update links to its source and shows when AMMS verified it.
Latest source review
Search all 729 updates
November 2025
4 updatesCourt reviews discovery and proof of injury in Depo-Provera cases
Depo-Provera litigation. MDL 3140, Case Management Order 8, docket entry 487.
FDA approves reformulated ranitidine tablets
Five years after requesting withdrawal of the earlier products, FDA approved reformulated tablets following safety testing and manufacturing changes addressing NDMA formation during storage. The approval included updated storage and handling instructions.
Bankruptcy judge confirms a revised Purdue plan
New York’s attorney general reported that the bankruptcy judge confirmed Purdue’s plan in a ruling from the bench. Confirmation was a step toward carrying out the $7.4 billion settlement with Purdue and the Sackler family.
Need campaign information?
Browse all campaignsReview the source, status, and intake path together.
Each campaign page includes its supporting sources, records checklist, FAQs, and review form.